Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples